These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 23952102

  • 1. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD, Angele MK, Schwarz B, Pratschke S, Rentsch M, Khandoga A, Guba M, Jauch KW, Bruns C, Graeb C.
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [Abstract] [Full Text] [Related]

  • 2. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS, Sint Nicolaas J, Kwekkeboom J, de Man RA, Kazemier G, Tilanus HW, Hansen BE, van der Laan LJ, Tha-In T, Metselaar HJ.
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [Abstract] [Full Text] [Related]

  • 3. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H, European and Australian Investigators in Lung Transplantation.
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [Abstract] [Full Text] [Related]

  • 5. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
    Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL.
    Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
    [Abstract] [Full Text] [Related]

  • 6. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W, Albani J, Englert C, Spehr A, Grabhorn E, Kemper MJ, Burdelski M, Ganschow R.
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [Abstract] [Full Text] [Related]

  • 7. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H, Walschburger-Zorn K, Häberle L, Wach S, Engehausen DG, Wullich B.
    Clin Transplant; 2013 Dec; 27(1):E30-6. PubMed ID: 23278453
    [Abstract] [Full Text] [Related]

  • 8. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
    Rademacher S, Seehofer D, Eurich D, Schoening W, Neuhaus R, Oellinger R, Denecke T, Pascher A, Schott E, Sinn M, Neuhaus P, Pratschke J.
    Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of de novo allergy in pediatric liver transplantation--10 yr experience of a single center.
    Lee Y, Lee YM, Kim MJ, Lee SK, Choe YH.
    Pediatr Transplant; 2013 May; 17(3):251-5. PubMed ID: 23405954
    [Abstract] [Full Text] [Related]

  • 10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 11. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
    Carenco C, Faure S, Herrero A, Assenat E, Duny Y, Danan G, Bismuth M, Chanques G, Ursic-Bedoya J, Jaber S, Larrey D, Navarro F, Pageaux GP.
    Liver Int; 2015 Jun; 35(6):1748-55. PubMed ID: 25488375
    [Abstract] [Full Text] [Related]

  • 12. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J.
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [Abstract] [Full Text] [Related]

  • 13. Non-lymphoid cancer after liver transplantation.
    Frezza EE, Fung JJ, van Thiel DH.
    Hepatogastroenterology; 1997 May; 44(16):1172-81. PubMed ID: 9261620
    [Abstract] [Full Text] [Related]

  • 14. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
    Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ.
    Transplantation; 1998 Nov 15; 66(9):1193-200. PubMed ID: 9825817
    [Abstract] [Full Text] [Related]

  • 15. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U, Adani GL, Montanaro D, Risaliti A, Lorenzin D, Avellini C, Tulissi P, Groppuzzo M, Currò G, Luvisetto F, Beltrami A, Bresadola V, Viale PL, Bresadola F.
    Transplant Proc; 2006 May 15; 38(4):1135-7. PubMed ID: 16757287
    [Abstract] [Full Text] [Related]

  • 16. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May 15; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 18. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, Settmacher U, Neuhaus P.
    Int Immunopharmacol; 2005 Jan 15; 5(1):125-8. PubMed ID: 15589470
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, Rossi M, Lake J, Munn S, Mühlbacher F, Leonardi L, Cillo U.
    Transplant Proc; 2006 Nov 15; 38(9):2964-7. PubMed ID: 17112875
    [Abstract] [Full Text] [Related]

  • 20. Burden of de novo malignancy in the liver transplant recipient.
    Chandok N, Watt KD.
    Liver Transpl; 2012 Nov 15; 18(11):1277-89. PubMed ID: 22887956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.